nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—sarcoma—lung cancer	0.173	1	CtDrD
Mitoxantrone—Topoisomerase Inhibitors—Teniposide—lung cancer	0.124	0.276	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Topotecan—lung cancer	0.111	0.246	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Irinotecan—lung cancer	0.0941	0.209	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Etoposide—lung cancer	0.0739	0.164	CiPCiCtD
Mitoxantrone—ABCG2—lung cancer	0.054	0.452	CbGaD
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—lung cancer	0.047	0.105	CiPCiCtD
Mitoxantrone—CYP2E1—lung cancer	0.0429	0.359	CbGaD
Mitoxantrone—ABCB1—lung cancer	0.0225	0.188	CbGaD
Mitoxantrone—TOP2A—Teniposide—lung cancer	0.0183	0.108	CbGbCtD
Mitoxantrone—CYP1B1—Erlotinib—lung cancer	0.00869	0.0514	CbGbCtD
Mitoxantrone—TOP2A—Etoposide—lung cancer	0.00805	0.0476	CbGbCtD
Mitoxantrone—CYP1B1—Paclitaxel—lung cancer	0.00795	0.047	CbGbCtD
Mitoxantrone—ABCG2—Topotecan—lung cancer	0.00764	0.0452	CbGbCtD
Mitoxantrone—ABCG2—Gefitinib—lung cancer	0.00698	0.0413	CbGbCtD
Mitoxantrone—ABCG2—Teniposide—lung cancer	0.00677	0.0401	CbGbCtD
Mitoxantrone—CYP1B1—Docetaxel—lung cancer	0.00575	0.034	CbGbCtD
Mitoxantrone—ABCC1—Paclitaxel—lung cancer	0.00565	0.0334	CbGbCtD
Mitoxantrone—ABCC1—Irinotecan—lung cancer	0.00557	0.033	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—lung cancer	0.00549	0.0325	CbGbCtD
Mitoxantrone—ABCC1—Vinblastine—lung cancer	0.00495	0.0293	CbGbCtD
Mitoxantrone—ABCC1—Etoposide—lung cancer	0.00446	0.0264	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—lung cancer	0.00429	0.0254	CbGbCtD
Mitoxantrone—ABCG2—Erlotinib—lung cancer	0.00413	0.0244	CbGbCtD
Mitoxantrone—ABCC1—Docetaxel—lung cancer	0.00408	0.0242	CbGbCtD
Mitoxantrone—ABCG2—Paclitaxel—lung cancer	0.00378	0.0224	CbGbCtD
Mitoxantrone—ABCG2—Irinotecan—lung cancer	0.00373	0.0221	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—lung cancer	0.00304	0.018	CbGbCtD
Mitoxantrone—ABCG2—Cisplatin—lung cancer	0.00304	0.018	CbGbCtD
Mitoxantrone—ABCG2—Etoposide—lung cancer	0.00299	0.0177	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—lung cancer	0.00295	0.0174	CbGbCtD
Mitoxantrone—ABCB1—Topotecan—lung cancer	0.00275	0.0163	CbGbCtD
Mitoxantrone—ABCG2—Docetaxel—lung cancer	0.00273	0.0162	CbGbCtD
Mitoxantrone—ABCB1—Gefitinib—lung cancer	0.00252	0.0149	CbGbCtD
Mitoxantrone—CYP2E1—Etoposide—lung cancer	0.00213	0.0126	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—lung cancer	0.00204	0.0121	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—lung cancer	0.00197	0.0117	CbGbCtD
Mitoxantrone—ABCB1—Vinorelbine—lung cancer	0.00194	0.0115	CbGbCtD
Mitoxantrone—CYP3A4—Topotecan—lung cancer	0.00165	0.00976	CbGbCtD
Mitoxantrone—ABCB1—Crizotinib—lung cancer	0.00154	0.00913	CbGbCtD
Mitoxantrone—CYP3A4—Gefitinib—lung cancer	0.00151	0.00893	CbGbCtD
Mitoxantrone—ABCB1—Gemcitabine—lung cancer	0.00151	0.00893	CbGbCtD
Mitoxantrone—ABCB1—Erlotinib—lung cancer	0.00149	0.00881	CbGbCtD
Mitoxantrone—CYP3A4—Teniposide—lung cancer	0.00146	0.00866	CbGbCtD
Mitoxantrone—ABCB1—Paclitaxel—lung cancer	0.00136	0.00806	CbGbCtD
Mitoxantrone—ABCB1—Irinotecan—lung cancer	0.00134	0.00796	CbGbCtD
Mitoxantrone—ABCB1—Vinblastine—lung cancer	0.0012	0.00707	CbGbCtD
Mitoxantrone—CYP3A4—Vinorelbine—lung cancer	0.00116	0.00688	CbGbCtD
Mitoxantrone—ABCB1—Cisplatin—lung cancer	0.0011	0.00649	CbGbCtD
Mitoxantrone—ABCB1—Etoposide—lung cancer	0.00108	0.00637	CbGbCtD
Mitoxantrone—ABCB1—Docetaxel—lung cancer	0.000985	0.00583	CbGbCtD
Mitoxantrone—CYP3A4—Crizotinib—lung cancer	0.000925	0.00547	CbGbCtD
Mitoxantrone—CYP3A4—Erlotinib—lung cancer	0.000892	0.00528	CbGbCtD
Mitoxantrone—CYP3A4—Paclitaxel—lung cancer	0.000817	0.00483	CbGbCtD
Mitoxantrone—PIM1—mammary gland—lung cancer	0.000816	0.103	CbGeAlD
Mitoxantrone—CYP3A4—Irinotecan—lung cancer	0.000806	0.00477	CbGbCtD
Mitoxantrone—ABCB1—Doxorubicin—lung cancer	0.000735	0.00435	CbGbCtD
Mitoxantrone—CYP3A4—Vinblastine—lung cancer	0.000716	0.00424	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—lung cancer	0.000712	0.00421	CbGbCtD
Mitoxantrone—CYP3A4—Etoposide—lung cancer	0.000645	0.00382	CbGbCtD
Mitoxantrone—CYP3A4—Docetaxel—lung cancer	0.00059	0.00349	CbGbCtD
Mitoxantrone—PIM1—respiratory system—lung cancer	0.000544	0.0686	CbGeAlD
Mitoxantrone—BTK—bronchus—lung cancer	0.000517	0.0652	CbGeAlD
Mitoxantrone—PIM1—bronchus—lung cancer	0.000447	0.0565	CbGeAlD
Mitoxantrone—CYP3A4—Doxorubicin—lung cancer	0.00044	0.0026	CbGbCtD
Mitoxantrone—PIM1—trachea—lung cancer	0.000402	0.0507	CbGeAlD
Mitoxantrone—PIM1—cardiac atrium—lung cancer	0.000377	0.0476	CbGeAlD
Mitoxantrone—BTK—bone marrow—lung cancer	0.000368	0.0464	CbGeAlD
Mitoxantrone—BTK—lung—lung cancer	0.000333	0.0421	CbGeAlD
Mitoxantrone—CYP1B1—mammary gland—lung cancer	0.00032	0.0404	CbGeAlD
Mitoxantrone—PIM1—bone marrow—lung cancer	0.000319	0.0402	CbGeAlD
Mitoxantrone—PIM1—lung—lung cancer	0.000289	0.0364	CbGeAlD
Mitoxantrone—TOP2A—bronchus—lung cancer	0.000262	0.0331	CbGeAlD
Mitoxantrone—BTK—lymph node—lung cancer	0.000228	0.0288	CbGeAlD
Mitoxantrone—CYP1B1—respiratory system—lung cancer	0.000214	0.0269	CbGeAlD
Mitoxantrone—PIM1—lymph node—lung cancer	0.000197	0.0249	CbGeAlD
Mitoxantrone—TOP2A—bone marrow—lung cancer	0.000187	0.0236	CbGeAlD
Mitoxantrone—TOP2A—lung—lung cancer	0.000169	0.0214	CbGeAlD
Mitoxantrone—ABCC1—bronchus—lung cancer	0.000158	0.0199	CbGeAlD
Mitoxantrone—SLC47A1—lung—lung cancer	0.000155	0.0195	CbGeAlD
Mitoxantrone—ABCC1—trachea—lung cancer	0.000142	0.0179	CbGeAlD
Mitoxantrone—CYP2E1—respiratory system—lung cancer	0.000138	0.0174	CbGeAlD
Mitoxantrone—ABCC1—cardiac atrium—lung cancer	0.000133	0.0168	CbGeAlD
Mitoxantrone—TOP2A—lymph node—lung cancer	0.000116	0.0146	CbGeAlD
Mitoxantrone—CYP1B1—lung—lung cancer	0.000113	0.0143	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—lung cancer	0.000106	0.0133	CbGeAlD
Mitoxantrone—ABCC1—lung—lung cancer	0.000102	0.0129	CbGeAlD
Mitoxantrone—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000102	0.097	CbGdCrCtD
Mitoxantrone—ABCG2—bone marrow—lung cancer	9.32e-05	0.0118	CbGeAlD
Mitoxantrone—TOP2A—Irinotecan—Topotecan—lung cancer	8.7e-05	0.0831	CbGdCrCtD
Mitoxantrone—ABCG2—lung—lung cancer	8.44e-05	0.0107	CbGeAlD
Mitoxantrone—ABCB1—respiratory system—lung cancer	7.84e-05	0.00989	CbGeAlD
Mitoxantrone—CYP1B1—lymph node—lung cancer	7.75e-05	0.00978	CbGeAlD
Mitoxantrone—TOP2A—Erlotinib—Gefitinib—lung cancer	7.59e-05	0.0725	CbGdCrCtD
Mitoxantrone—CYP2E1—lung—lung cancer	7.31e-05	0.00922	CbGeAlD
Mitoxantrone—TOP2A—Topotecan—Irinotecan—lung cancer	7.23e-05	0.069	CbGdCrCtD
Mitoxantrone—TOP2A—Etoposide—Teniposide—lung cancer	7.19e-05	0.0686	CbGdCrCtD
Mitoxantrone—ABCC1—lymph node—lung cancer	6.97e-05	0.0088	CbGeAlD
Mitoxantrone—ABCB1—epithelium—lung cancer	6.55e-05	0.00827	CbGeAlD
Mitoxantrone—TOP2A—Vindesine—Vinorelbine—lung cancer	6.47e-05	0.0617	CbGdCrCtD
Mitoxantrone—ABCB1—trachea—lung cancer	5.79e-05	0.00731	CbGeAlD
Mitoxantrone—ABCG2—lymph node—lung cancer	5.77e-05	0.00729	CbGeAlD
Mitoxantrone—TOP2A—Podofilox—Teniposide—lung cancer	5.48e-05	0.0523	CbGdCrCtD
Mitoxantrone—TOP2A—Vindesine—Vinblastine—lung cancer	5.17e-05	0.0493	CbGdCrCtD
Mitoxantrone—TOP2A—Methotrexate—Pemetrexed—lung cancer	5.16e-05	0.0492	CbGdCrCtD
Mitoxantrone—TOP2A—Paclitaxel—Docetaxel—lung cancer	5.07e-05	0.0484	CbGdCrCtD
Mitoxantrone—TOP2A—Afatinib—Gefitinib—lung cancer	4.96e-05	0.0474	CbGdCrCtD
Mitoxantrone—TOP2A—Gefitinib—Erlotinib—lung cancer	4.87e-05	0.0465	CbGdCrCtD
Mitoxantrone—ABCB1—bone marrow—lung cancer	4.59e-05	0.0058	CbGeAlD
Mitoxantrone—ABCB1—lung—lung cancer	4.16e-05	0.00525	CbGeAlD
Mitoxantrone—TOP2A—Vincristine—Vinorelbine—lung cancer	3.49e-05	0.0333	CbGdCrCtD
Mitoxantrone—TOP2A—Vinorelbine—Vinblastine—lung cancer	3.26e-05	0.0311	CbGdCrCtD
Mitoxantrone—TOP2A—Teniposide—Etoposide—lung cancer	3.26e-05	0.0311	CbGdCrCtD
Mitoxantrone—TOP2A—Podofilox—Etoposide—lung cancer	3.26e-05	0.0311	CbGdCrCtD
Mitoxantrone—ABCB1—lymph node—lung cancer	2.85e-05	0.00359	CbGeAlD
Mitoxantrone—TOP2A—Vinblastine—Vinorelbine—lung cancer	2.81e-05	0.0268	CbGdCrCtD
Mitoxantrone—TOP2A—Vincristine—Vinblastine—lung cancer	2.79e-05	0.0266	CbGdCrCtD
Mitoxantrone—TOP2A—Cytarabine—Gemcitabine—lung cancer	1.83e-05	0.0175	CbGdCrCtD
Mitoxantrone—Decreased appetite—Cisplatin—lung cancer	1.69e-05	0.000337	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Paclitaxel—lung cancer	1.69e-05	0.000336	CcSEcCtD
Mitoxantrone—Pneumonia—Methotrexate—lung cancer	1.68e-05	0.000335	CcSEcCtD
Mitoxantrone—Anaemia—Docetaxel—lung cancer	1.68e-05	0.000334	CcSEcCtD
Mitoxantrone—Drowsiness—Methotrexate—lung cancer	1.67e-05	0.000333	CcSEcCtD
Mitoxantrone—Anorexia—Paclitaxel—lung cancer	1.67e-05	0.000331	CcSEcCtD
Mitoxantrone—Hypotension—Etoposide—lung cancer	1.67e-05	0.000331	CcSEcCtD
Mitoxantrone—Pain—Cisplatin—lung cancer	1.66e-05	0.000331	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Doxorubicin—lung cancer	1.66e-05	0.00033	CcSEcCtD
Mitoxantrone—Vomiting—Vinorelbine—lung cancer	1.65e-05	0.000329	CcSEcCtD
Mitoxantrone—Body temperature increased—Gemcitabine—lung cancer	1.65e-05	0.000328	CcSEcCtD
Mitoxantrone—Renal failure—Methotrexate—lung cancer	1.65e-05	0.000327	CcSEcCtD
Mitoxantrone—Rash—Vinorelbine—lung cancer	1.64e-05	0.000326	CcSEcCtD
Mitoxantrone—Dermatitis—Vinorelbine—lung cancer	1.64e-05	0.000326	CcSEcCtD
Mitoxantrone—Hypotension—Paclitaxel—lung cancer	1.63e-05	0.000325	CcSEcCtD
Mitoxantrone—Stomatitis—Methotrexate—lung cancer	1.63e-05	0.000325	CcSEcCtD
Mitoxantrone—Headache—Vinorelbine—lung cancer	1.63e-05	0.000324	CcSEcCtD
Mitoxantrone—Conjunctivitis—Methotrexate—lung cancer	1.63e-05	0.000324	CcSEcCtD
Mitoxantrone—Leukopenia—Docetaxel—lung cancer	1.63e-05	0.000323	CcSEcCtD
Mitoxantrone—Sweating—Methotrexate—lung cancer	1.61e-05	0.000319	CcSEcCtD
Mitoxantrone—Feeling abnormal—Cisplatin—lung cancer	1.6e-05	0.000319	CcSEcCtD
Mitoxantrone—Paraesthesia—Etoposide—lung cancer	1.6e-05	0.000318	CcSEcCtD
Mitoxantrone—Haematuria—Methotrexate—lung cancer	1.6e-05	0.000318	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Paclitaxel—lung cancer	1.59e-05	0.000317	CcSEcCtD
Mitoxantrone—Dyspnoea—Etoposide—lung cancer	1.59e-05	0.000316	CcSEcCtD
Mitoxantrone—Somnolence—Etoposide—lung cancer	1.59e-05	0.000315	CcSEcCtD
Mitoxantrone—Cough—Docetaxel—lung cancer	1.58e-05	0.000315	CcSEcCtD
Mitoxantrone—Hypersensitivity—Irinotecan—lung cancer	1.58e-05	0.000314	CcSEcCtD
Mitoxantrone—Convulsion—Docetaxel—lung cancer	1.57e-05	0.000313	CcSEcCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—lung cancer	1.57e-05	0.015	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—lung cancer	1.57e-05	0.015	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—lung cancer	1.57e-05	0.015	CbGdCrCtD
Mitoxantrone—Paraesthesia—Paclitaxel—lung cancer	1.57e-05	0.000312	CcSEcCtD
Mitoxantrone—Hypertension—Docetaxel—lung cancer	1.57e-05	0.000312	CcSEcCtD
Mitoxantrone—Agranulocytosis—Methotrexate—lung cancer	1.56e-05	0.000311	CcSEcCtD
Mitoxantrone—Dyspnoea—Paclitaxel—lung cancer	1.56e-05	0.00031	CcSEcCtD
Mitoxantrone—Somnolence—Paclitaxel—lung cancer	1.55e-05	0.000309	CcSEcCtD
Mitoxantrone—Decreased appetite—Etoposide—lung cancer	1.55e-05	0.000308	CcSEcCtD
Mitoxantrone—Chest pain—Docetaxel—lung cancer	1.55e-05	0.000307	CcSEcCtD
Mitoxantrone—Myalgia—Docetaxel—lung cancer	1.55e-05	0.000307	CcSEcCtD
Mitoxantrone—Arthralgia—Docetaxel—lung cancer	1.55e-05	0.000307	CcSEcCtD
Mitoxantrone—Pancytopenia—Doxorubicin—lung cancer	1.54e-05	0.000307	CcSEcCtD
Mitoxantrone—Nausea—Vinorelbine—lung cancer	1.54e-05	0.000307	CcSEcCtD
Mitoxantrone—Dyspepsia—Paclitaxel—lung cancer	1.54e-05	0.000306	CcSEcCtD
Mitoxantrone—Body temperature increased—Cisplatin—lung cancer	1.54e-05	0.000306	CcSEcCtD
Mitoxantrone—Asthenia—Irinotecan—lung cancer	1.54e-05	0.000306	CcSEcCtD
Mitoxantrone—Fatigue—Etoposide—lung cancer	1.54e-05	0.000306	CcSEcCtD
Mitoxantrone—Pain—Etoposide—lung cancer	1.52e-05	0.000303	CcSEcCtD
Mitoxantrone—Constipation—Etoposide—lung cancer	1.52e-05	0.000303	CcSEcCtD
Mitoxantrone—Neutropenia—Doxorubicin—lung cancer	1.52e-05	0.000302	CcSEcCtD
Mitoxantrone—Decreased appetite—Paclitaxel—lung cancer	1.52e-05	0.000302	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Doxorubicin—lung cancer	1.51e-05	0.000301	CcSEcCtD
Mitoxantrone—Haemoglobin—Methotrexate—lung cancer	1.51e-05	0.000301	CcSEcCtD
Mitoxantrone—Fatigue—Paclitaxel—lung cancer	1.51e-05	0.0003	CcSEcCtD
Mitoxantrone—Haemorrhage—Methotrexate—lung cancer	1.5e-05	0.000299	CcSEcCtD
Mitoxantrone—Hepatitis—Methotrexate—lung cancer	1.5e-05	0.000299	CcSEcCtD
Mitoxantrone—Asthenia—Gemcitabine—lung cancer	1.5e-05	0.000298	CcSEcCtD
Mitoxantrone—Constipation—Paclitaxel—lung cancer	1.5e-05	0.000297	CcSEcCtD
Mitoxantrone—Pain—Paclitaxel—lung cancer	1.5e-05	0.000297	CcSEcCtD
Mitoxantrone—Confusional state—Docetaxel—lung cancer	1.49e-05	0.000297	CcSEcCtD
Mitoxantrone—Pharyngitis—Methotrexate—lung cancer	1.49e-05	0.000297	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Docetaxel—lung cancer	1.48e-05	0.000295	CcSEcCtD
Mitoxantrone—Oedema—Docetaxel—lung cancer	1.48e-05	0.000295	CcSEcCtD
Mitoxantrone—Weight increased—Doxorubicin—lung cancer	1.48e-05	0.000294	CcSEcCtD
Mitoxantrone—Infection—Docetaxel—lung cancer	1.47e-05	0.000293	CcSEcCtD
Mitoxantrone—Weight decreased—Doxorubicin—lung cancer	1.47e-05	0.000293	CcSEcCtD
Mitoxantrone—Feeling abnormal—Etoposide—lung cancer	1.47e-05	0.000292	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Doxorubicin—lung cancer	1.47e-05	0.000292	CcSEcCtD
Mitoxantrone—Diarrhoea—Irinotecan—lung cancer	1.47e-05	0.000292	CcSEcCtD
Mitoxantrone—Pneumonia—Doxorubicin—lung cancer	1.46e-05	0.00029	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Etoposide—lung cancer	1.46e-05	0.00029	CcSEcCtD
Mitoxantrone—Shock—Docetaxel—lung cancer	1.46e-05	0.00029	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Docetaxel—lung cancer	1.45e-05	0.000289	CcSEcCtD
Mitoxantrone—Drowsiness—Doxorubicin—lung cancer	1.45e-05	0.000288	CcSEcCtD
Mitoxantrone—Tachycardia—Docetaxel—lung cancer	1.45e-05	0.000288	CcSEcCtD
Mitoxantrone—Feeling abnormal—Paclitaxel—lung cancer	1.44e-05	0.000287	CcSEcCtD
Mitoxantrone—Skin disorder—Docetaxel—lung cancer	1.44e-05	0.000286	CcSEcCtD
Mitoxantrone—Hypersensitivity—Cisplatin—lung cancer	1.43e-05	0.000285	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Paclitaxel—lung cancer	1.43e-05	0.000284	CcSEcCtD
Mitoxantrone—Diarrhoea—Gemcitabine—lung cancer	1.43e-05	0.000284	CcSEcCtD
Mitoxantrone—Renal failure—Doxorubicin—lung cancer	1.43e-05	0.000284	CcSEcCtD
Mitoxantrone—Urticaria—Etoposide—lung cancer	1.42e-05	0.000282	CcSEcCtD
Mitoxantrone—Stomatitis—Doxorubicin—lung cancer	1.41e-05	0.000281	CcSEcCtD
Mitoxantrone—Jaundice—Doxorubicin—lung cancer	1.41e-05	0.000281	CcSEcCtD
Mitoxantrone—Anorexia—Docetaxel—lung cancer	1.41e-05	0.000281	CcSEcCtD
Mitoxantrone—Abdominal pain—Etoposide—lung cancer	1.41e-05	0.00028	CcSEcCtD
Mitoxantrone—Body temperature increased—Etoposide—lung cancer	1.41e-05	0.00028	CcSEcCtD
Mitoxantrone—Urinary tract infection—Doxorubicin—lung cancer	1.41e-05	0.00028	CcSEcCtD
Mitoxantrone—Conjunctivitis—Doxorubicin—lung cancer	1.41e-05	0.00028	CcSEcCtD
Mitoxantrone—Asthenia—Cisplatin—lung cancer	1.4e-05	0.000278	CcSEcCtD
Mitoxantrone—Sweating—Doxorubicin—lung cancer	1.39e-05	0.000276	CcSEcCtD
Mitoxantrone—Urticaria—Paclitaxel—lung cancer	1.39e-05	0.000276	CcSEcCtD
Mitoxantrone—Hypotension—Docetaxel—lung cancer	1.38e-05	0.000275	CcSEcCtD
Mitoxantrone—Haematuria—Doxorubicin—lung cancer	1.38e-05	0.000275	CcSEcCtD
Mitoxantrone—Abdominal pain—Paclitaxel—lung cancer	1.38e-05	0.000275	CcSEcCtD
Mitoxantrone—Body temperature increased—Paclitaxel—lung cancer	1.38e-05	0.000275	CcSEcCtD
Mitoxantrone—Vomiting—Irinotecan—lung cancer	1.36e-05	0.000271	CcSEcCtD
Mitoxantrone—Sinusitis—Doxorubicin—lung cancer	1.36e-05	0.000271	CcSEcCtD
Mitoxantrone—Agranulocytosis—Doxorubicin—lung cancer	1.35e-05	0.000269	CcSEcCtD
Mitoxantrone—Rash—Irinotecan—lung cancer	1.35e-05	0.000269	CcSEcCtD
Mitoxantrone—Dermatitis—Irinotecan—lung cancer	1.35e-05	0.000269	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Docetaxel—lung cancer	1.35e-05	0.000269	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—lung cancer	1.35e-05	0.000268	CcSEcCtD
Mitoxantrone—Headache—Irinotecan—lung cancer	1.34e-05	0.000267	CcSEcCtD
Mitoxantrone—Diarrhoea—Cisplatin—lung cancer	1.33e-05	0.000265	CcSEcCtD
Mitoxantrone—Paraesthesia—Docetaxel—lung cancer	1.33e-05	0.000265	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—lung cancer	1.33e-05	0.000264	CcSEcCtD
Mitoxantrone—Vomiting—Gemcitabine—lung cancer	1.33e-05	0.000264	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—lung cancer	1.33e-05	0.000264	CcSEcCtD
Mitoxantrone—Dyspnoea—Docetaxel—lung cancer	1.32e-05	0.000263	CcSEcCtD
Mitoxantrone—Somnolence—Docetaxel—lung cancer	1.32e-05	0.000262	CcSEcCtD
Mitoxantrone—Rash—Gemcitabine—lung cancer	1.32e-05	0.000262	CcSEcCtD
Mitoxantrone—Dermatitis—Gemcitabine—lung cancer	1.32e-05	0.000262	CcSEcCtD
Mitoxantrone—TOP2A—Azacitidine—Gemcitabine—lung cancer	1.31e-05	0.0125	CbGdCrCtD
Mitoxantrone—Hypersensitivity—Etoposide—lung cancer	1.31e-05	0.000261	CcSEcCtD
Mitoxantrone—Erythema—Methotrexate—lung cancer	1.31e-05	0.00026	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—lung cancer	1.31e-05	0.00026	CcSEcCtD
Mitoxantrone—Headache—Gemcitabine—lung cancer	1.31e-05	0.00026	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—lung cancer	1.3e-05	0.00026	CcSEcCtD
Mitoxantrone—Dyspepsia—Docetaxel—lung cancer	1.3e-05	0.000259	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—lung cancer	1.3e-05	0.000259	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—lung cancer	1.3e-05	0.000259	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—lung cancer	1.29e-05	0.000257	CcSEcCtD
Mitoxantrone—Decreased appetite—Docetaxel—lung cancer	1.29e-05	0.000256	CcSEcCtD
Mitoxantrone—Hypersensitivity—Paclitaxel—lung cancer	1.29e-05	0.000256	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—lung cancer	1.28e-05	0.000255	CcSEcCtD
Mitoxantrone—Asthenia—Etoposide—lung cancer	1.28e-05	0.000254	CcSEcCtD
Mitoxantrone—Fatigue—Docetaxel—lung cancer	1.28e-05	0.000254	CcSEcCtD
Mitoxantrone—Nausea—Irinotecan—lung cancer	1.27e-05	0.000253	CcSEcCtD
Mitoxantrone—Pain—Docetaxel—lung cancer	1.27e-05	0.000252	CcSEcCtD
Mitoxantrone—Constipation—Docetaxel—lung cancer	1.27e-05	0.000252	CcSEcCtD
Mitoxantrone—Back pain—Methotrexate—lung cancer	1.27e-05	0.000252	CcSEcCtD
Mitoxantrone—Asthenia—Paclitaxel—lung cancer	1.25e-05	0.000249	CcSEcCtD
Mitoxantrone—Nausea—Gemcitabine—lung cancer	1.24e-05	0.000247	CcSEcCtD
Mitoxantrone—Vomiting—Cisplatin—lung cancer	1.24e-05	0.000246	CcSEcCtD
Mitoxantrone—Vision blurred—Methotrexate—lung cancer	1.23e-05	0.000245	CcSEcCtD
Mitoxantrone—Rash—Cisplatin—lung cancer	1.23e-05	0.000244	CcSEcCtD
Mitoxantrone—Dermatitis—Cisplatin—lung cancer	1.23e-05	0.000244	CcSEcCtD
Mitoxantrone—Feeling abnormal—Docetaxel—lung cancer	1.22e-05	0.000243	CcSEcCtD
Mitoxantrone—Diarrhoea—Etoposide—lung cancer	1.22e-05	0.000243	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Methotrexate—lung cancer	1.21e-05	0.000242	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Docetaxel—lung cancer	1.21e-05	0.000241	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—lung cancer	1.21e-05	0.000241	CcSEcCtD
Mitoxantrone—Diarrhoea—Paclitaxel—lung cancer	1.2e-05	0.000238	CcSEcCtD
Mitoxantrone—Malaise—Methotrexate—lung cancer	1.18e-05	0.000235	CcSEcCtD
Mitoxantrone—Body temperature increased—Docetaxel—lung cancer	1.17e-05	0.000233	CcSEcCtD
Mitoxantrone—Abdominal pain—Docetaxel—lung cancer	1.17e-05	0.000233	CcSEcCtD
Mitoxantrone—Leukopenia—Methotrexate—lung cancer	1.17e-05	0.000233	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—lung cancer	1.17e-05	0.000232	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—lung cancer	1.16e-05	0.000231	CcSEcCtD
Mitoxantrone—Nausea—Cisplatin—lung cancer	1.16e-05	0.00023	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—lung cancer	1.15e-05	0.000229	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—lung cancer	1.14e-05	0.000227	CcSEcCtD
Mitoxantrone—Convulsion—Methotrexate—lung cancer	1.13e-05	0.000226	CcSEcCtD
Mitoxantrone—Vomiting—Etoposide—lung cancer	1.13e-05	0.000225	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—lung cancer	1.13e-05	0.000225	CcSEcCtD
Mitoxantrone—Rash—Etoposide—lung cancer	1.12e-05	0.000224	CcSEcCtD
Mitoxantrone—Dermatitis—Etoposide—lung cancer	1.12e-05	0.000223	CcSEcCtD
Mitoxantrone—Headache—Etoposide—lung cancer	1.12e-05	0.000222	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—lung cancer	1.11e-05	0.000222	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—lung cancer	1.11e-05	0.000222	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—lung cancer	1.11e-05	0.000222	CcSEcCtD
Mitoxantrone—Vomiting—Paclitaxel—lung cancer	1.11e-05	0.000221	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—lung cancer	1.11e-05	0.000221	CcSEcCtD
Mitoxantrone—Rash—Paclitaxel—lung cancer	1.1e-05	0.000219	CcSEcCtD
Mitoxantrone—Dermatitis—Paclitaxel—lung cancer	1.1e-05	0.000219	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—lung cancer	1.1e-05	0.000219	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—lung cancer	1.1e-05	0.000218	CcSEcCtD
Mitoxantrone—Headache—Paclitaxel—lung cancer	1.1e-05	0.000218	CcSEcCtD
Mitoxantrone—Hypersensitivity—Docetaxel—lung cancer	1.09e-05	0.000217	CcSEcCtD
Mitoxantrone—Confusional state—Methotrexate—lung cancer	1.08e-05	0.000214	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—lung cancer	1.07e-05	0.000212	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—lung cancer	1.07e-05	0.000212	CcSEcCtD
Mitoxantrone—Asthenia—Docetaxel—lung cancer	1.06e-05	0.000211	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—lung cancer	1.06e-05	0.000211	CcSEcCtD
Mitoxantrone—Nausea—Etoposide—lung cancer	1.06e-05	0.000211	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—lung cancer	1.05e-05	0.000209	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—lung cancer	1.05e-05	0.000208	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Methotrexate—lung cancer	1.05e-05	0.000208	CcSEcCtD
Mitoxantrone—Nausea—Paclitaxel—lung cancer	1.04e-05	0.000207	CcSEcCtD
Mitoxantrone—Skin disorder—Methotrexate—lung cancer	1.04e-05	0.000206	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methotrexate—lung cancer	1.03e-05	0.000205	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—lung cancer	1.02e-05	0.000203	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—lung cancer	1.02e-05	0.000202	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—lung cancer	1.01e-05	0.000202	CcSEcCtD
Mitoxantrone—Diarrhoea—Docetaxel—lung cancer	1.01e-05	0.000202	CcSEcCtD
Mitoxantrone—Hypotension—Methotrexate—lung cancer	9.98e-06	0.000199	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—lung cancer	9.89e-06	0.000197	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—lung cancer	9.82e-06	0.000195	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—lung cancer	9.78e-06	0.000195	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—lung cancer	9.73e-06	0.000194	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—lung cancer	9.65e-06	0.000192	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—lung cancer	9.65e-06	0.000192	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—lung cancer	9.65e-06	0.000192	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—lung cancer	9.61e-06	0.000191	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—lung cancer	9.59e-06	0.000191	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—lung cancer	9.53e-06	0.00019	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—lung cancer	9.52e-06	0.000189	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—lung cancer	9.49e-06	0.000189	CcSEcCtD
Mitoxantrone—Vomiting—Docetaxel—lung cancer	9.42e-06	0.000187	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—lung cancer	9.4e-06	0.000187	CcSEcCtD
Mitoxantrone—Rash—Docetaxel—lung cancer	9.34e-06	0.000186	CcSEcCtD
Mitoxantrone—Dermatitis—Docetaxel—lung cancer	9.33e-06	0.000186	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—lung cancer	9.32e-06	0.000185	CcSEcCtD
Mitoxantrone—Decreased appetite—Methotrexate—lung cancer	9.28e-06	0.000185	CcSEcCtD
Mitoxantrone—Headache—Docetaxel—lung cancer	9.28e-06	0.000185	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—lung cancer	9.25e-06	0.000184	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—lung cancer	9.25e-06	0.000184	CcSEcCtD
Mitoxantrone—Fatigue—Methotrexate—lung cancer	9.21e-06	0.000183	CcSEcCtD
Mitoxantrone—Infection—Doxorubicin—lung cancer	9.19e-06	0.000183	CcSEcCtD
Mitoxantrone—Pain—Methotrexate—lung cancer	9.13e-06	0.000182	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—lung cancer	9.1e-06	0.000181	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Doxorubicin—lung cancer	9.05e-06	0.00018	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—lung cancer	9.03e-06	0.00018	CcSEcCtD
Mitoxantrone—Skin disorder—Doxorubicin—lung cancer	8.98e-06	0.000179	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—lung cancer	8.94e-06	0.000178	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—lung cancer	8.82e-06	0.000175	CcSEcCtD
Mitoxantrone—Nausea—Docetaxel—lung cancer	8.8e-06	0.000175	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methotrexate—lung cancer	8.8e-06	0.000175	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methotrexate—lung cancer	8.73e-06	0.000174	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—lung cancer	8.64e-06	0.000172	CcSEcCtD
Mitoxantrone—Urticaria—Methotrexate—lung cancer	8.48e-06	0.000169	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—lung cancer	8.44e-06	0.000168	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—lung cancer	8.44e-06	0.000168	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.43e-06	0.000168	CcSEcCtD
Mitoxantrone—Paraesthesia—Doxorubicin—lung cancer	8.3e-06	0.000165	CcSEcCtD
Mitoxantrone—Dyspnoea—Doxorubicin—lung cancer	8.24e-06	0.000164	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—lung cancer	8.22e-06	0.000164	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—lung cancer	8.14e-06	0.000162	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—lung cancer	8.04e-06	0.00016	CcSEcCtD
Mitoxantrone—Fatigue—Doxorubicin—lung cancer	7.97e-06	0.000159	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—lung cancer	7.91e-06	0.000157	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—lung cancer	7.91e-06	0.000157	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methotrexate—lung cancer	7.87e-06	0.000157	CcSEcCtD
Mitoxantrone—Asthenia—Methotrexate—lung cancer	7.66e-06	0.000152	CcSEcCtD
Mitoxantrone—Feeling abnormal—Doxorubicin—lung cancer	7.62e-06	0.000152	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—lung cancer	7.56e-06	0.00015	CcSEcCtD
Mitoxantrone—Urticaria—Doxorubicin—lung cancer	7.35e-06	0.000146	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—lung cancer	7.31e-06	0.000145	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—lung cancer	7.31e-06	0.000145	CcSEcCtD
Mitoxantrone—Diarrhoea—Methotrexate—lung cancer	7.31e-06	0.000145	CcSEcCtD
Mitoxantrone—Hypersensitivity—Doxorubicin—lung cancer	6.81e-06	0.000136	CcSEcCtD
Mitoxantrone—Vomiting—Methotrexate—lung cancer	6.79e-06	0.000135	CcSEcCtD
Mitoxantrone—Rash—Methotrexate—lung cancer	6.73e-06	0.000134	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—lung cancer	6.73e-06	0.000134	CcSEcCtD
Mitoxantrone—Headache—Methotrexate—lung cancer	6.69e-06	0.000133	CcSEcCtD
Mitoxantrone—Asthenia—Doxorubicin—lung cancer	6.64e-06	0.000132	CcSEcCtD
Mitoxantrone—Nausea—Methotrexate—lung cancer	6.34e-06	0.000126	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—lung cancer	6.33e-06	0.000126	CcSEcCtD
Mitoxantrone—Vomiting—Doxorubicin—lung cancer	5.88e-06	0.000117	CcSEcCtD
Mitoxantrone—Rash—Doxorubicin—lung cancer	5.83e-06	0.000116	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—lung cancer	5.83e-06	0.000116	CcSEcCtD
Mitoxantrone—Headache—Doxorubicin—lung cancer	5.79e-06	0.000115	CcSEcCtD
Mitoxantrone—Nausea—Doxorubicin—lung cancer	5.49e-06	0.000109	CcSEcCtD
Mitoxantrone—ABCG2—Metabolism—CYP2E1—lung cancer	2.4e-06	8.18e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GNG11—lung cancer	2.39e-06	8.18e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—lung cancer	2.37e-06	8.1e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NQO1—lung cancer	2.37e-06	8.09e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—STK11—lung cancer	2.35e-06	8.02e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.34e-06	8.01e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA3—lung cancer	2.34e-06	7.99e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RRM1—lung cancer	2.34e-06	7.99e-05	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—lung cancer	2.33e-06	7.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERCC2—lung cancer	2.32e-06	7.91e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALDOA—lung cancer	2.28e-06	7.78e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.28e-06	7.78e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB3—lung cancer	2.27e-06	7.74e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	2.26e-06	7.72e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTP1—lung cancer	2.25e-06	7.67e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—lung cancer	2.24e-06	7.65e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLBD1—lung cancer	2.24e-06	7.64e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	2.23e-06	7.62e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.22e-06	7.58e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NCOA3—lung cancer	2.21e-06	7.56e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.2e-06	7.53e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—B4GALT5—lung cancer	2.2e-06	7.51e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CAT—lung cancer	2.19e-06	7.46e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.17e-06	7.42e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTP1—lung cancer	2.17e-06	7.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TERT—lung cancer	2.17e-06	7.42e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.16e-06	7.37e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADCY1—lung cancer	2.15e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCG2—lung cancer	2.15e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA4—lung cancer	2.14e-06	7.3e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—STK11—lung cancer	2.14e-06	7.3e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—lung cancer	2.13e-06	7.26e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CAT—lung cancer	2.11e-06	7.22e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HPGDS—lung cancer	2.11e-06	7.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ENO2—lung cancer	2.11e-06	7.21e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.11e-06	7.21e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR1—lung cancer	2.11e-06	7.2e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.1e-06	7.18e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPP2R1B—lung cancer	2.1e-06	7.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TYMS—lung cancer	2.09e-06	7.13e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA2—lung cancer	2.08e-06	7.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HIF1A—lung cancer	2.08e-06	7.09e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTM1—lung cancer	2.06e-06	7.05e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—lung cancer	2.06e-06	7.03e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—lung cancer	2.06e-06	7.02e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTT1—lung cancer	2.05e-06	6.99e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD17B10—lung cancer	2.04e-06	6.98e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GCLC—lung cancer	2.02e-06	6.91e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2A6—lung cancer	2.02e-06	6.91e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TYMS—lung cancer	2.02e-06	6.9e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA1—lung cancer	2.01e-06	6.87e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOA1—lung cancer	2e-06	6.85e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—lung cancer	2e-06	6.82e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.99e-06	6.81e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCC3—lung cancer	1.99e-06	6.79e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTP1—lung cancer	1.98e-06	6.75e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1A1—lung cancer	1.96e-06	6.68e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ERCC2—lung cancer	1.94e-06	6.63e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKR1C1—lung cancer	1.93e-06	6.58e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAT—lung cancer	1.92e-06	6.57e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ENO1—lung cancer	1.92e-06	6.55e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—lung cancer	1.9e-06	6.5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CKB—lung cancer	1.9e-06	6.49e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP1A1—lung cancer	1.89e-06	6.46e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ERCC2—lung cancer	1.88e-06	6.41e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—lung cancer	1.87e-06	6.39e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—UGT1A1—lung cancer	1.87e-06	6.38e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMS—lung cancer	1.84e-06	6.28e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.83e-06	6.25e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APC—lung cancer	1.83e-06	6.25e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KIT—lung cancer	1.83e-06	6.25e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—lung cancer	1.82e-06	6.22e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—lung cancer	1.82e-06	6.2e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGF—lung cancer	1.81e-06	6.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GNG11—lung cancer	1.8e-06	6.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM2—lung cancer	1.79e-06	6.1e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CNDP2—lung cancer	1.79e-06	6.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.77e-06	6.05e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTMR3—lung cancer	1.74e-06	5.94e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1A1—lung cancer	1.72e-06	5.88e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BRAF—lung cancer	1.72e-06	5.87e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDOA—lung cancer	1.72e-06	5.86e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ERCC2—lung cancer	1.71e-06	5.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.71e-06	5.82e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NQO1—lung cancer	1.7e-06	5.81e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6R—lung cancer	1.7e-06	5.8e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CREBBP—lung cancer	1.7e-06	5.79e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PGAM1—lung cancer	1.69e-06	5.79e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—lung cancer	1.68e-06	5.74e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOA1—lung cancer	1.68e-06	5.73e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOA3—lung cancer	1.67e-06	5.69e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOA1—lung cancer	1.62e-06	5.55e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADCY1—lung cancer	1.62e-06	5.54e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCG2—lung cancer	1.62e-06	5.54e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAP2K1—lung cancer	1.62e-06	5.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2A7—lung cancer	1.62e-06	5.52e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CD—lung cancer	1.61e-06	5.49e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.61e-06	5.49e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HPGDS—lung cancer	1.59e-06	5.43e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO2—lung cancer	1.59e-06	5.43e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SDC4—lung cancer	1.58e-06	5.4e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPP2R1B—lung cancer	1.58e-06	5.39e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.55e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTT1—lung cancer	1.54e-06	5.27e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—STK11—lung cancer	1.53e-06	5.24e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—lung cancer	1.53e-06	5.23e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2A6—lung cancer	1.52e-06	5.2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GCLC—lung cancer	1.52e-06	5.2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.5e-06	5.11e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—lung cancer	1.48e-06	5.06e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOA1—lung cancer	1.48e-06	5.05e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POMC—lung cancer	1.46e-06	4.98e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO1—lung cancer	1.44e-06	4.93e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.44e-06	4.93e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MDM2—lung cancer	1.44e-06	4.92e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA3—lung cancer	1.44e-06	4.92e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RRM1—lung cancer	1.44e-06	4.92e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RAF1—lung cancer	1.44e-06	4.91e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CREBBP—lung cancer	1.42e-06	4.85e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—lung cancer	1.42e-06	4.85e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTP1—lung cancer	1.42e-06	4.85e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POMC—lung cancer	1.41e-06	4.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTOR—lung cancer	1.4e-06	4.79e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CB—lung cancer	1.4e-06	4.79e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—lung cancer	1.4e-06	4.78e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—lung cancer	1.39e-06	4.75e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAT—lung cancer	1.38e-06	4.72e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CREBBP—lung cancer	1.37e-06	4.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—B4GALT5—lung cancer	1.35e-06	4.63e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.35e-06	4.61e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—lung cancer	1.35e-06	4.61e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CD—lung cancer	1.35e-06	4.6e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—lung cancer	1.34e-06	4.59e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—lung cancer	1.33e-06	4.54e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMS—lung cancer	1.32e-06	4.51e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA4—lung cancer	1.32e-06	4.5e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—lung cancer	1.3e-06	4.45e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CD—lung cancer	1.3e-06	4.45e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2E1—lung cancer	1.3e-06	4.43e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—lung cancer	1.29e-06	4.39e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA2—lung cancer	1.28e-06	4.39e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POMC—lung cancer	1.28e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NQO1—lung cancer	1.28e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CREBBP—lung cancer	1.25e-06	4.27e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA1—lung cancer	1.24e-06	4.23e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A1—lung cancer	1.24e-06	4.22e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ERCC2—lung cancer	1.23e-06	4.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCC3—lung cancer	1.22e-06	4.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.22e-06	4.17e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1A—lung cancer	1.21e-06	4.15e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—lung cancer	1.21e-06	4.14e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKR1C1—lung cancer	1.19e-06	4.05e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CD—lung cancer	1.19e-06	4.05e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CB—lung cancer	1.17e-06	4.01e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—lung cancer	1.17e-06	4e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—lung cancer	1.16e-06	3.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EP300—lung cancer	1.16e-06	3.95e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—STK11—lung cancer	1.15e-06	3.94e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UGT1A1—lung cancer	1.15e-06	3.93e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CB—lung cancer	1.14e-06	3.88e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—lung cancer	1.13e-06	3.84e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SRC—lung cancer	1.12e-06	3.84e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GNG11—lung cancer	1.11e-06	3.79e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—lung cancer	1.08e-06	3.7e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—lung cancer	1.08e-06	3.69e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTP1—lung cancer	1.07e-06	3.65e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOA1—lung cancer	1.06e-06	3.62e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDOA—lung cancer	1.06e-06	3.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAT—lung cancer	1.04e-06	3.55e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK3—lung cancer	1.04e-06	3.54e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CB—lung cancer	1.03e-06	3.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOA3—lung cancer	1.03e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—lung cancer	1.02e-06	3.5e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—lung cancer	1.01e-06	3.47e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—lung cancer	1.01e-06	3.44e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADCY1—lung cancer	9.99e-07	3.41e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCG2—lung cancer	9.99e-07	3.41e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMS—lung cancer	9.93e-07	3.39e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—lung cancer	9.85e-07	3.36e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—lung cancer	9.82e-07	3.35e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—lung cancer	9.82e-07	3.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HPGDS—lung cancer	9.79e-07	3.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO2—lung cancer	9.79e-07	3.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.73e-07	3.32e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—lung cancer	9.68e-07	3.31e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—EP300—lung cancer	9.68e-07	3.31e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTT1—lung cancer	9.5e-07	3.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCLC—lung cancer	9.39e-07	3.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2A6—lung cancer	9.39e-07	3.21e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—EP300—lung cancer	9.36e-07	3.2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A1—lung cancer	9.31e-07	3.18e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—lung cancer	9.31e-07	3.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ERCC2—lung cancer	9.23e-07	3.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POMC—lung cancer	9.22e-07	3.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CREBBP—lung cancer	8.98e-07	3.07e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—lung cancer	8.93e-07	3.05e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO1—lung cancer	8.9e-07	3.04e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—lung cancer	8.55e-07	2.92e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—EP300—lung cancer	8.52e-07	2.91e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CD—lung cancer	8.51e-07	2.91e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—lung cancer	8.4e-07	2.87e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOA1—lung cancer	7.99e-07	2.73e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2E1—lung cancer	7.98e-07	2.73e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—lung cancer	7.91e-07	2.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NQO1—lung cancer	7.89e-07	2.7e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—lung cancer	7.57e-07	2.59e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CB—lung cancer	7.42e-07	2.53e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—lung cancer	7.35e-07	2.51e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—lung cancer	7.29e-07	2.49e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—lung cancer	7.16e-07	2.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STK11—lung cancer	7.12e-07	2.43e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—lung cancer	6.98e-07	2.39e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POMC—lung cancer	6.94e-07	2.37e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—lung cancer	6.92e-07	2.36e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CREBBP—lung cancer	6.76e-07	2.31e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTP1—lung cancer	6.58e-07	2.25e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—lung cancer	6.41e-07	2.19e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CD—lung cancer	6.41e-07	2.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAT—lung cancer	6.41e-07	2.19e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—lung cancer	6.33e-07	2.16e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—lung cancer	6.3e-07	2.15e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—lung cancer	6.23e-07	2.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMS—lung cancer	6.12e-07	2.09e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—EP300—lung cancer	6.11e-07	2.09e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—lung cancer	6.05e-07	2.07e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—lung cancer	5.85e-07	2e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A1—lung cancer	5.74e-07	1.96e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ERCC2—lung cancer	5.69e-07	1.94e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—lung cancer	5.66e-07	1.93e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CB—lung cancer	5.59e-07	1.91e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—lung cancer	5.54e-07	1.89e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—lung cancer	5.15e-07	1.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOA1—lung cancer	4.92e-07	1.68e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—lung cancer	4.83e-07	1.65e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—EP300—lung cancer	4.6e-07	1.57e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—lung cancer	4.52e-07	1.54e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—lung cancer	4.49e-07	1.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POMC—lung cancer	4.28e-07	1.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CREBBP—lung cancer	4.17e-07	1.42e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CD—lung cancer	3.95e-07	1.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—lung cancer	3.9e-07	1.33e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—lung cancer	3.69e-07	1.26e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CB—lung cancer	3.44e-07	1.18e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—lung cancer	3.41e-07	1.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—lung cancer	3.41e-07	1.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—lung cancer	2.97e-07	1.02e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EP300—lung cancer	2.84e-07	9.69e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—lung cancer	2.78e-07	9.5e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—lung cancer	2.1e-07	7.17e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—lung cancer	1.71e-07	5.85e-06	CbGpPWpGaD
